[Recent advances in therapies for haemophilia].
作者信息
Sun B Y, Yang R C
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2018 Oct 14;39(10):873-876. doi: 10.3760/cma.j.issn.0253-2727.2018.10.018.
Abstract
摘要
相似文献
1
[Recent advances in therapies for haemophilia].[血友病治疗的最新进展]
Zhonghua Xue Ye Xue Za Zhi. 2018 Oct 14;39(10):873-876. doi: 10.3760/cma.j.issn.0253-2727.2018.10.018.
2
Haemophilia: factoring in new therapies.血友病：新疗法的考量。
Br J Haematol. 2021 Sep;194(5):835-850. doi: 10.1111/bjh.17580. Epub 2021 Jul 28.
3
Advances in the management of haemophilia: emerging treatments and their mechanisms.血友病治疗新进展：新兴疗法及其作用机制。
J Biomed Sci. 2021 Sep 14;28(1):64. doi: 10.1186/s12929-021-00760-4.
4
Advances and innovations in haemophilia treatment.血友病治疗的进展与创新。
Nat Rev Drug Discov. 2018 Jul;17(7):493-508. doi: 10.1038/nrd.2018.70. Epub 2018 Jun 8.
5
A preliminary application of a haemophilia value framework to emerging therapies in haemophilia.血友病价值框架在血友病新兴疗法中的初步应用。
Haemophilia. 2022 Mar;28 Suppl 2:9-18. doi: 10.1111/hae.14511.
6
Targeting higher factor VIII levels for prophylaxis in haemophilia A: a narrative review.提高血友病A预防性治疗的凝血因子VIII水平：一项叙述性综述
Haemophilia. 2023 Nov;29(6):1419-1429. doi: 10.1111/hae.14866. Epub 2023 Sep 27.
7
An Update on the Dental Management of Children with Haemophilia.儿童血友病的口腔管理更新。
Prim Dent J. 2021 Dec;10(4):45-51. doi: 10.1177/20501684211066241.
8
Therapy for haemophilia: recent advances and goals for the future.血友病的治疗：近期进展与未来目标
Expert Opin Emerg Drugs. 2005 Feb;10(1):173-84. doi: 10.1517/14728214.10.1.173.
9
Benefits and risks of non-factor therapies: Redefining haemophilia treatment goals in the era of new technologies.非因子疗法的获益与风险：在新技术时代重新定义血友病治疗目标。
Haemophilia. 2024 Apr;30 Suppl 3:39-44. doi: 10.1111/hae.14976. Epub 2024 Mar 13.
10
Defining success in haemophilia care - Are we doing it right?定义血友病护理的成功——我们做对了吗？
Haemophilia. 2024 Apr;30 Suppl 3:52-59. doi: 10.1111/hae.14958. Epub 2024 Mar 18.
引用本文的文献
1
[Advances in long-acting recombinant factor Ⅸ for the treatment of hemophilia B].用于治疗B型血友病的长效重组凝血因子Ⅸ的研究进展
Zhonghua Xue Ye Xue Za Zhi. 2022 Mar 14;43(3):259-264. doi: 10.3760/cma.j.issn.0253-2727.2022.03.014.
本文引用的文献
1
Thromboembolic Risks of Non-Factor Replacement Therapies in Hemophilia.血友病中非凝血因子替代疗法的血栓栓塞风险
Hamostaseologie. 2017;37(4):307-310. doi: 10.5482/20170004. Epub 2017 Dec 28.
2
Recent advances in developing specific therapies for haemophilia.血友病特异性治疗方法的最新进展。
Br J Haematol. 2018 Apr;181(2):161-172. doi: 10.1111/bjh.15084. Epub 2018 Jan 23.
3
Gene therapy comes of age.基因治疗走向成熟。
Science. 2018 Jan 12;359(6372). doi: 10.1126/science.aan4672.
4
Targeting anticoagulant protein S to improve hemostasis in hemophilia.靶向抗凝蛋白 S 以改善血友病的止血功能。
Blood. 2018 Mar 22;131(12):1360-1371. doi: 10.1182/blood-2017-09-800326. Epub 2018 Jan 9.
5
Hemophilia gene therapy comes of age.血友病基因疗法已走向成熟。
Blood Adv. 2017 Dec 8;1(26):2591-2599. doi: 10.1182/bloodadvances.2017009878. eCollection 2017 Dec 12.
6
Gene therapy with adeno-associated virus vector 5-human factor IX in adults with hemophilia B.腺相关病毒载体 5-人凝血因子 IX 基因治疗乙型血友病成人患者。
Blood. 2018 Mar 1;131(9):1022-1031. doi: 10.1182/blood-2017-09-804419. Epub 2017 Dec 15.
7
AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.AAV5-Factor VIII 基因治疗重度血友病 A。
N Engl J Med. 2017 Dec 28;377(26):2519-2530. doi: 10.1056/NEJMoa1708483. Epub 2017 Dec 9.
8
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.采用高特异性活性因子IX变体的B型血友病基因疗法。
N Engl J Med. 2017 Dec 7;377(23):2215-2227. doi: 10.1056/NEJMoa1708538.
9
Strategy to detect pre-existing immunity to AAV gene therapy.检测 AAV 基因治疗中预先存在免疫的策略。
Gene Ther. 2017 Dec;24(12):768-778. doi: 10.1038/gt.2017.95. Epub 2017 Nov 6.
10
Novel approaches to hemophilia therapy: successes and challenges.血友病治疗的新方法：成功与挑战
Blood. 2017 Nov 23;130(21):2251-2256. doi: 10.1182/blood-2017-08-742312. Epub 2017 Oct 10.
Zotero 插件